Christopher R. Shubert

Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study

John R. Bergquist, Carlos A. Puig, Christopher R. Shubert et al. · Journal of the American College of Surgeons · 2016 · 159 citations

Medicine, Oncology, Gastrointestinal Oncology +11

Clinical Risk Score to Predict Pancreatic Fistula after Pancreatoduodenectomy: Independent External Validation for Open and Laparoscopic Approaches

Christopher R. Shubert, Amy E. Wagie, Michael B. Farnell et al. · Journal of the American College of Surgeons · 2015 · 118 citations

Medicine, Surgery, Diagnostic Assessment +16

Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response

Toni T. Seppälä, Jacquelyn W. Zimmerman, Reecha Suri et al. · Clinical Cancer Research · 2022 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database

Christopher R. Shubert, John R. Bergquist, Ryan T. Groeschl et al. · Surgery · 2016 · 83 citations

Medicine, Oncology, Surgery +11

Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience

Zhaohui Jin, Mindy L. Hartgers, Cristobal T. Sanhueza et al. · European Journal of Surgical Oncology · 2018 · 55 citations

Medicine, Oncology, Surgery +17